Table 1 Demographic characteristics and clinical data in combination therapy group (RS) and control group (mean ± SD)
Variable | Control group (n = 115) | RS group (n = 115) | F or X2 (p value) |
|---|---|---|---|
Gender(male/female) | 62/53 | 66/49 | 0.3 (0.60) |
Age (years) | 26.2 ± 6.6 | 26.1 ± 5.9 | 0.01 (0.92) |
Education (years) | 11.9 ± 2.3 | 12.4 ± 2.5 | 2.2 (0.14) |
Age of onset (years) | 24.0 ± 5.8 | 23.6 ± 5.2 | 0.2 (0.67) |
Duration of illness (years) | 2.2 ± 1.6 | 2.5 ± 1.8 | 1.8 (0.19) |
Prolactin (ug/ml) | 254.7 ± 54.9 | 259.1 ± 59.5 | 0.6 (0.44) |
P | 24.9 ± 6.2 | 23.9 ± 6.3 | 1.4 (0.24) |
N | 28.9 ± 6.1 | 30.2 ± 7.2 | 2.3 (0.14) |
G | 58.3 ± 8.8 | 59.9 ± 8.8 | 1.7 (0.19) |
PANSS total score | 112.2 ± 12.5 | 114.0 ± 13.4 | 1.2 (0.27) |
HAMD total score | 24.3 ± 4.8 | 24.8 ± 5.7 | 0.4 (0.51) |
PSP total score | 34.9 ± 5.2 | 34.2 ± 3.6 | 1.7 (0.20) |
CGI-S total score | 5.9 ± 0.7 | 5.8 ± 0.6 | 0.1 (0.77) |